SHAREHOLDER ALERT: Potential Recovery for Apellis Pharmaceuticals, Inc. (APLS) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit
News provided byACCESSWIRE
Sep 18, 2023, 11:15 PM ET
NEW YORK, NY / ACCESSWIRE / September 18, 2023 / If you suffered a loss on your Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/apellis-lawsuit-submission-form?prid=48760&wire=1 or contact Joseph E. Levi, Esq. via email at firstname.lastname@example.org or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
THE LAWSUIT: A class action securities lawsuit was filed against Apellis Pharmaceuticals, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between January 28, 2021 and July 28, 2023.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) the design of SYFOVRE's clinical trials was insufficient to identify incidents of retinal vasculitis in patients receiving SYFOVRE injections; (2) as a result, the commercial adoption of SYFOVRE was subject to significant, unknown risk factors; and (3) therefore, defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.
WHAT'S NEXT? If you suffered a loss in Apellis stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/apellis-lawsuit-submission-form?prid=48760&wire=1 to learn about your rights to seek a recovery. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com:
NOTE: This content is not written by or endorsed by "KFDX/KJTL", its advertisers, or Nexstar Media Inc.